149 related articles for article (PubMed ID: 7972106)
1. Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells.
Woffendin C; Yang ZY; Udaykumar ; Xu L; Yang NS; Sheehy MJ; Nabel GJ
Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11581-5. PubMed ID: 7972106
[TBL] [Abstract][Full Text] [Related]
2. Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients.
Woffendin C; Ranga U; Yang Z; Xu L; Nabel GJ
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2889-94. PubMed ID: 8610137
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator.
Bevec D; Dobrovnik M; Hauber J; Böhnlein E
Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9870-4. PubMed ID: 1409715
[TBL] [Abstract][Full Text] [Related]
4. Genetic modification of human peripheral blood lymphocytes with a transdominant negative form of Rev: safety and toxicity.
Fox BA; Woffendin C; Yang ZY; San H; Ranga U; Gordon D; Osterholzer J; Nabel GJ
Hum Gene Ther; 1995 Aug; 6(8):997-1004. PubMed ID: 7578421
[TBL] [Abstract][Full Text] [Related]
5. Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication.
Malim MH; Freimuth WW; Liu J; Boyle TJ; Lyerly HK; Cullen BR; Nabel GJ
J Exp Med; 1992 Oct; 176(4):1197-201. PubMed ID: 1402661
[TBL] [Abstract][Full Text] [Related]
6. Analysis of trans-dominant mutants of the HIV type 1 Rev protein for their ability to inhibit Rev function, HIV type 1 replication, and their use as anti-HIV gene therapeutics.
Ragheb JA; Bressler P; Daucher M; Chiang L; Chuah MK; VandenDriessche T; Morgan RA
AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1343-53. PubMed ID: 8573391
[TBL] [Abstract][Full Text] [Related]
7. Constitutive expression of chimeric neo-Rev response element transcripts suppresses HIV-1 replication in human CD4+ T lymphocytes.
Bevec D; Volc-Platzer B; Zimmermann K; Dobrovnik M; Hauber J; Veres G; Böhnlein E
Hum Gene Ther; 1994 Feb; 5(2):193-201. PubMed ID: 8186299
[TBL] [Abstract][Full Text] [Related]
8. A Rev-inducible mutant gag gene stably transferred into T lymphocytes: an approach to gene therapy against human immunodeficiency virus type 1 infection.
Smythe JA; Sun D; Thomson M; Markham PD; Reitz MS; Gallo RC; Lisziewicz J
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3657-61. PubMed ID: 8170964
[TBL] [Abstract][Full Text] [Related]
9. Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals.
Ranga U; Woffendin C; Verma S; Xu L; June CH; Bishop DK; Nabel GJ
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1201-6. PubMed ID: 9448309
[TBL] [Abstract][Full Text] [Related]
10. Comparison of trans-dominant inhibitory mutant human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes.
Bahner I; Zhou C; Yu XJ; Hao QL; Guatelli JC; Kohn DB
J Virol; 1993 Jun; 67(6):3199-207. PubMed ID: 8388497
[TBL] [Abstract][Full Text] [Related]
11. Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual.
Iversen AK; Shpaer EG; Rodrigo AG; Hirsch MS; Walker BD; Sheppard HW; Merigan TC; Mullins JI
J Virol; 1995 Sep; 69(9):5743-53. PubMed ID: 7637019
[TBL] [Abstract][Full Text] [Related]
12. Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells.
Liu J; Woffendin C; Yang ZY; Nabel GJ
Gene Ther; 1994 Jan; 1(1):32-7. PubMed ID: 7584057
[TBL] [Abstract][Full Text] [Related]
13. RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication.
Bonyhadi ML; Moss K; Voytovich A; Auten J; Kalfoglou C; Plavec I; Forestell S; Su L; Böhnlein E; Kaneshima H
J Virol; 1997 Jun; 71(6):4707-16. PubMed ID: 9151864
[TBL] [Abstract][Full Text] [Related]
14. The development and testing of retroviral vectors expressing trans-dominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance.
Liem SE; Ramezani A; Li X; Joshi S
Hum Gene Ther; 1993 Oct; 4(5):625-34. PubMed ID: 8280800
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for AIDS using retroviral mediated gene transfer to deliver HIV-1 antisense TAR and transdominant Rev protein genes to syngeneic lymphocytes in HIV-1 infected identical twins.
Morgan RA; Walker R
Hum Gene Ther; 1996 Jun; 7(10):1281-306. PubMed ID: 8793552
[No Abstract] [Full Text] [Related]
16. Use of a human immunodeficiency virus type 1 Rev mutant without nucleolar dysfunction as a candidate for potential AIDS therapy.
Furuta RA; Kubota S; Maki M; Miyazaki Y; Hattori T; Hatanaka M
J Virol; 1995 Mar; 69(3):1591-9. PubMed ID: 7853493
[TBL] [Abstract][Full Text] [Related]
17. Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts.
Adams M; Sharmeen L; Kimpton J; Romeo JM; Garcia JV; Peterlin BM; Groudine M; Emerman M
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3862-6. PubMed ID: 8171003
[TBL] [Abstract][Full Text] [Related]
18. Intracellular immunization against HIV-1 infection of human T lymphocytes: utility of anti-rev single-chain variable fragments.
Duan L; Zhu M; Bagasra O; Pomerantz RJ
Hum Gene Ther; 1995 Dec; 6(12):1561-73. PubMed ID: 8664381
[TBL] [Abstract][Full Text] [Related]
19. Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication.
Klimatcheva E; Planelles V; Day SL; Fulreader F; Renda MJ; Rosenblatt J
Mol Ther; 2001 Jun; 3(6):928-39. PubMed ID: 11407907
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 gene rev responsible for accumulated heterodisperse RNAs seen in infected T-cells.
Lindström E; Koga Y; Wigzell H
Virology; 1992 Jan; 186(1):335-8. PubMed ID: 1370129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
